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Myeloid cell leukemia sequence-1 (Mcl-1) is a critical anti-apoptotic factor in T lymphocytes. However, in spite of the many
pro-apoptotic proteins with proposed binding to Mcl-1, the speciﬁc interactions by which Mcl-1 regulates primary T-cell survival
under different conditions have not been fully explored. Further, how different trophic cytokines modulate the speciﬁc role(s) of
Mcl-1isunknown.Here,weusegeneticmousemodelstodissecttherolesofMcl-1inprimaryTlymphocytes.Usingtheinducible
Mcl-1-ﬂoxed estrogen receptor-Cre fusion protein (Mcl-1
f/fERCre) deletion system in combination with genetic modiﬁcation of
other B-cell lymphoma 2 (Bcl-2) family members, we show that loss of pro-apoptotic Bcl-2 homologous antagonist/killer (Bak)
rescues the survival of Mcl-1-deﬁcient T cells in the presence of IL-7. Without IL-7, the survival of Mcl-1-deﬁcient cells cannot be
rescued by loss of Bak, but is partially rescued by overexpression of Bcl-2 or loss of Bcl-2-interacting mediator of cell death
(Bim). Thus, Mcl-1 and Bcl-2 have a shared role, the inhibition of Bim, in promoting T-cell survival during cytokine withdrawal.
Finally, we show that other common gamma-chain (cc) cytokines differentially modulate the roles of Mcl-1. IL-15 has effects
similar to those of IL-7 in memory T cells and naı ¨ve CD8
þ cells, but not naı ¨ve CD4
þ cells. However, IL-4 maintains Mcl-1 and
Bcl-2 but also upregulates Bim and Bcl-2-associated X protein (Bax), thus altering the cell’s dependence on Mcl-1.
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The balanced production, maintenance, replication, and
clearance of T cells is termed as homeostasis. Antigen-
inexperienced (‘naı ¨ve’) T cells require homeostatic
signals, typically low-level signals from self-peptide-major
histocompatibility complex (MHC), and the cytokine IL-7.
1
Upon activation, T cells expand into effector populations
before ‘contracting’ into antigen-experienced (‘memory’)
populations that are retained over time. Unlike naı ¨ve cells,
memory cells do not require self-peptide-MHC and can utilize
IL-15 for survival.
1
IL-7 and other cytokines, namely IL-2, IL-15, IL-4, IL-9, and
IL-21, constitute a family that shares the gc-receptor subunit.
The cytokine receptors are composed of the gc subunit with
one or two other subunit(s), some shared and some unique.
Each cytokine has a distinct biological role, although several
of them, particularly IL-7 and IL-15, promote T-cell survival.
2
Studies from mice, primary cells, and cell lines have
implicated the B-cell lymphoma-2 (Bcl-2) family, speciﬁcally
the Bcl-2/Bcl-2-interacting mediator of cell death (Bim)/Bcl-2-
associated X protein (Bax) axis, downstream of cytokine
signaling,
3 but the role of myeloid cell leukemia sequence-1
(Mcl-1) in cytokine-induced survival is less well described.
The Bcl-2 family proteins are deﬁned as sharing one or
more Bcl-2 homology (BH) domains. Pro-apoptotic Bcl-2
homologous antagonist/killer (Bak) and Bax self-oligomerize
to form pores in mitochondrial membranes, and are required
for the intrinsic pathway of apoptosis.
4,5 Pro-apoptotic BH3-
only proteins, such as Bim, Bid, Bad, Noxa, and Puma, are
upstream initiators. Anti-apoptotic proteins, including Bcl-2,
Mcl-1, and Bcl-xL, have been proposed to function both by
inhibiting the BH3-only proteins and by inhibiting Bak/Bax.
6–11
Which of these roles is dominant has been debated and has
not been thoroughly explored in vivo.
Knockout mouse models have demonstrated the impor-
tance of Bcl-2 family proteins in T-lymphocyte survival.
Bak/Bax double-knockout mice, but not single-knockouts,
exhibit increased numbers of T cells, T-cell resistance to
apoptosis, and defective thymic selection.
12,13 Both Bcl-2 and
Mcl-1 are required for survival in developing thymocytes and
mature T cells.
14–18 Inhibition of Bak by Mcl-1 is critical in
thymocytes: Bak deﬁciency, but not Bax deﬁciency or Bcl-2
overexpression, rescued the phenotype of Mcl-1-deﬁcient
thymocytes.
19 Although Bim is important in thymocyte
negative selection, and the Bim
 /  background rescued
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20–22 Bim deﬁciency did
not improve survival in Mcl-1-deﬁcient thymocytes.
19
Peripheral T cells die upon drug-induced deletion of Mcl-1
in vivo and under different in vitro conditions.
17,18 However,
the mechanism(s) by which Mcl-1 promotes peripheral T-cell
survival and the effect, if any, of trophic cytokines on these
mechanisms are not yet understood. In this study, we utilize
genetic models to investigate the mechanisms by which Mcl-1
promotes peripheral T-lymphocyte survival. We examine
the survival of Mcl-1-deﬁcient cells on Bak
 / , Bax
 / ,
Bim
 / , and Bcl-2-overexpressing backgrounds in the pre-
sence and absence of IL-7 and other gc-sharing cytokines.
The data highlight the complex pathways that regulate
primary T-cell survival, particularly the role of Mcl-1, and the
functions of gc cytokines.
Results
Mcl-1 is required for CD4
þ and CD8
þ,n a ı ¨ve and memory-
phenotype T-cell survival. The estrogen receptor-Cre fusion
protein (ERCre) allows deletion of ﬂoxed genes upon
addition of the drug tamoxifen, or its active metabolite
4-hydroxytamoxifen (4OHT).
23 We previously showed that
4OHT-treated T cells from Mcl-1-ﬂoxed, ERCre-expressing
(Mcl-1
f/fERCre) mice died under different ex vivo conditions.
18
As in vivo studies using this model were precluded by rapid
morbidity in tamoxifen-treated Mcl-1-ﬂoxed estrogen receptor-
Cre fusion protein (Mcl-1
f/fE R C r e )m i c e ,w eu s e dt h ein vitro
system to dissect the individual and combinatorial effects of
Bcl-2 family proteins and trophic cytokines on Mcl-1 activity.
To assess whether Mcl-1 deletion differentially affects
T-cell subsets, we examined survival in Mcl-1-deleted T-cell
subsets.ToassesstheeffectofIL-7,weaddedIL-7to1ng/ml,
a concentration that is commonly used in T-cell biology, and
that is thought to be physiological. Similar to previous
results,
18 CD4
þ and CD8
þ Mcl-1
f/fERCre T-cells had
reduced survival upon Mcl-1 deletion in a 3-day culture
of splenocytes in medium alone, with IL-7 (Figure 1a), and
with activating anti-CD3/CD28 antibodies (data not shown).
As baseline survival varied between conditions, we
calculated the ratio of survival with 4OHT to survival with
vehicle control (ethanol, EtOH) to have a better comparison of
the effect of Mcl-1 deletion. The magnitude of the reduction in
survivalupondeletionisa measureofMcl-1dependency. The
4OHT/EtOH survival ratio was approximately 1 in ERCre-
negative samples (Figure 1b). The reduction in survival was
more severe in cells cultured in medium alone than in those
cultured with IL-7, indicating greater dependence on Mcl-1
without IL-7 (Figure 1b). IL-7 enhanced survival in Mcl-1-
sufﬁcient (ERCre-negative and EtOH-treated) cells by 5–10-
fold, but enhanced survival in Mcl-1-deﬁcient cells by 20–30-
fold (Figure 1c).
We observed differences in absolute survival between
CD44
hi memory-phenotype and CD44
lo naı ¨ve cells
(Figure 1e, gating shown in Figure 1d). However, the relative
reduction in survival upon Mcl-1 deletion was similar between
CD44
hi and CD44
lo cells, and all T-cell subsets required Mcl-1
(Figure 1e). To conﬁrm that cells in our culture conditions
deleted Mcl-1, we assessed Mcl-1 protein expression by ﬂow
cytometry to allow side-by-side comparison of survival and
Mcl-1 levels. Although baseline Mcl-1 ﬂuorescence was quite
low, we detected a loss of Mcl-1 signal in 4OHT-treated cells
using the same time-point and culture conditions used
to assess survival (Figure 1f).
Bak
 /  rescues Mcl-1-deﬁcient T-cell survival in IL-7, but
not during cytokine withdrawal. In a previous study,
Bak deﬁciency rescued Mcl-1-deﬁcient thymocyte survival,
and we observed rescued T-cell numbers in Bak
 / Mcl-1
f/f
CD4Cre spleens.
19 To determine the importance of Bak
inhibition in peripheral T cells, we compared Mcl-1
f/fERCre
T-cell survival with that of Bak
 / Mcl-1
f/fERCre cells
following deletion. In medium alone, Bak
 / Mcl-1
f/fERCre
T cells survived no better than Mcl-1
f/fERCre cells as
measured by the percent survival or 4OHT/EtOH survival
ratio (Figures 2a and c). In contrast, the survival of
Bax
 / Mcl-1
f/fERCre T cells was slightly higher than that of
Bax
þ/þ controls, although the difference in the ratio was not
signiﬁcant for CD8
þ cells (Figures 2b and c). Bax has been
previously implicated in cytokine withdrawal-induced
apoptosis in thymocytes.
24
To better mimic homeostatic conditions, we added IL-7 to
the medium. 4OHT-treated Bak
 / Mcl-1
f/fERCre T cells had
comparable survival to EtOH-treated, wild-type, and Bak
 / 
ERCre
neg controls (Figures 2d and f). Bax deﬁciency did not
rescue Mcl-1-deleted T cells in IL-7 (Figures 2e and f).
To address the possibility that Bak deﬁciency altered the
kinetics of survival but not the ultimate fate of Mcl-1-deleted
cells, we assessed survival over a 5-day period. The Bak
 / 
background rescued Mcl-1-deﬁcient cell survival for 5 days
upon addition of a single dose of IL-7 at the beginning
of culture (Figure 2g).
To conﬁrm that the rescue of Mcl-1-deleted cells by
knockout genotypes was not due to the expansion of Mcl-1-
expressing cells (‘escapers’), we determined the relative
expression of Mcl-1 in knockout versus wild-type cells
at baseline and upon Mcl-1 deletion. Baseline Mcl-1 levels
in Bak
 /  and Bim
 /  (discussed below) cells were equivalent
to those in wild-type counterparts (Supplementary Figure S1).
Bax
 /  cells contained slightly higher levels of Mcl-1 than
Bax
þ/þ cells in the medium alone. Importantly, we did not
detect an increase in relative Mcl-1 expression in double-
knockout samples upon Mcl-1 deletion (Supplementary
Figure S1), indicating that rescue genotypes do not select
for escapers.
Bcl-2 rescues cytokine dependency, but not the
requirement for Mcl-1, in T cells. Bcl-2 overexpression
rescued T-cell development and survival in IL-7R
 /  mice
but failed to rescue Mcl-1-deﬁcient thymocyte
development.
19,25,26 To determine whether Bcl-2 modulates
Mcl-1-deﬁcient peripheral T-cell survival, we used mice
expressing a Bcl-2 transgene using the MHC class-I
promoter (Bcl-2
tg mice).
27 Bcl-2 overexpression rescued
undeleted T-cell survival in medium alone to the levels
observed with IL-7 (Figure 3a). We observed a slight
improvement over wild-type cells in Bax
 /  but not Bak
 / 
cell survival, but the modest improvement indicates that
cytokine withdrawal-induced apoptosis occurs largely
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Cell Death and Diseasethrough Bak or Bax (Figure 3a). Bim
 /  cells were resistant
to cytokine withdrawal-induced cell death (Figure 3a and
Bouillet P et al.
28).
Upon Mcl-1 deletion, Bcl-2
tgMcl-1
f/fERCre cells had
improved survival over Mcl-1
f/fERCre cells in medium alone
as measured by the percent survival and the 4OHT/EtOH
survival ratio (Figures 3b and d). Bcl-2 overexpression did not
completely rescue survival in 4OHT-treated Bcl-2
tgMcl-1
f/f
ERCre cells to EtOH control (percent survival, Figure 3b) or
wild-type (ratio, Figure 3d) levels. With IL-7, which induces
endogenous Bcl-2, the survival of Bcl-2
tgMcl-1
f/fERCre cells
was not different from that of Mcl-1
f/fERCre cells (Figures 3c
and e). Therefore, IL-7 and Bcl-2 have similar effects on Mcl-1
activity. In spite of the partial rescue during cytokine
withdrawal, Bcl-2 overexpression did not stabilize Mcl-1-
deﬁcient T-cell survival over time (Figure 3f), nor did Bcl-2
overexpression alter the kinetics of Mcl-1 deletion-induced
death in IL-7 (Figure 3g).
Figure 1 Mcl-1 is required for CD4
þ and CD8
þ, naı ¨ve and memory T cells. (a) Survival of CD4
þ and CD8
þ Mcl-1
f/fERCre and Mcl-1
f/f control T cells after a 3-day
culture of total splenocytes in medium alone and in medium with 1ng/ml IL-7. The percentage of live cells was assessed by PI exclusion. White bars represent cells cultured
in the ethanol vehicle control (EtOH), and black bars represent cells cultured in 4-hydroxytamoxifen (4OHT). The data represent the mean survival þS.E.M. of 12–15
experiments, each performed in triplicate. Here, n.s. signiﬁes that the P value is not signiﬁcant (PZ0.05) between the samples indicated. **Po0.01, ***Po0.001 versus
4OHT-treatedMcl-1
f/fcontrol.(b)Ratioofsurvivalin4OHTtosurvivalinEtOHofsplenocytesculturedfor3daysinmediumaloneandinmedium þIL-7.Theratioscalculated
from triplicate wells were determined for each experiment, and the bars represent the mean of the ratios þ the S.E.M. of 12–15 experiments. ***Po0.001 versus Mcl-1
f/f
control. (c) The enhancement of survival by IL-7 was calculated by dividing the percent survival (as assessed by PI exclusion) in medium with IL-7 (1ng/ml) by the survival in
medium alone for each cell type in both the EtOH control and 4OHT as indicated. The bars are the meanþS.E.M. of 11–14 independent experiments. (d) Gating of CD44
hi
andCD44
locellsfromtotalsplenocytecultures.Representativeﬂowcytometryplotsandhistogramsareshown.Cellswerepre-gatedonbothliveanddeadcellpopulationsby
forwardandsidescatter.(e)PercentsurvivingcellsbyPIexclusionintotalsplenocyteculturesgatedonCD44
hiandCD44
lopopulations.BarsarethemeanþS.D.oftriplicate
wells.(f)Mcl-1proteinexpressionwasassessedbyintracellularstainingforMcl-1incellsculturedfor3dayswithorwithout4OHT.Theshadedhistogramindicatestheisotype
control. Data are representative of three experiments, each with duplicate wells
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Cell Death and DiseaseBim
 /  partially rescues T-cell cytokine dependency, but
not the requirement for Mcl-1. Bim has been shown to
be induced by cytokine withdrawal, and to modulate
T-cell cytokine dependency.
28,29 We observed that Bim
 / 
cells survived better than wild-type cells during cytokine
withdrawal (Figure 3a). In medium alone, Bim
 / Mcl-1
f/f
ERCre T cells, particularly CD8
þ, had improved survival
compared with Mcl-1
f/fERCre cells (Figures 4a and b).
Similar to Bcl-2 overexpression, Bim deﬁciency did not
improve survival in IL-7 (Figures 4c and d). Therefore,
inhibiting Bim is not the major role of Mcl-1 in T cells in
IL-7, but Bim likely contributes to the accelerated death of
Mcl-1-deﬁcient T cells during cytokine withdrawal.
Modulation of the roles of Mcl-1 by cc cytokines. As IL-7
altered the role of Mcl-1 in T cells, we examined how other
cytokines of the gc family affected T-cell dependence on
Mcl-1. Naı ¨ve and memory T cells respond differently to
cytokines, so we examined the survival of CD44
lo and
CD44
hi T cells in the presence of different cytokines.
Although IL-2 promotes activated T-cell survival, resting
cells do not express the high-afﬁnity IL-2 receptor, and we
did not observe a survival response to IL-2 in our system
(data not shown). We selected concentrations of IL-4
and IL-15 that were previously shown to promote T-cell
survival and Mcl-1 expression (1–10ng/ml),
17,30 and a
dose–response experiment conﬁrmed that the lower
concentrations (0.1ng/ml) did not effectively promote T-cell
survival (Supplementary Figure S2). Consistent with
published results,
30,31 IL-4 at 1 and 10ng/ml improved the
survival of CD44
lo (Figure 5a) and CD44
hi (Figure 5b) T cells
over that of cells cultured in medium alone. The survival of
Figure2 Bak
 / butnotBax
 / rescuesthesurvivalofMcl-1-deﬁcientcellsinIL-7butnotduringcytokinewithdrawal.(aandb)PercentsurvivingBak
 / (a)andBax
 / 
(b) Mcl-1
f/f and Mcl-1
f/fERCre cells by PI exclusion after 3 days in culture in medium alone. Bars are the meanþS.D. of triplicate wells. Data are representative of three
independent experiments each for Bak
 /  and Bax
 / .* Po0.05 versus EtOH control within each genotype. (c) Survival ratios of Bak
 /  and Bax
 /  cells upon 3-day
culture in medium alone (RPMI). Bars are the meanþS.E.M. of three experiments. *Po0.05 between the ERCre
þ samples.
wPo0.05 between ERCre
þ and ERCre
neg
samples within the Bak
 /  (Bax
 /  in f) genotype. Here, ns indicates that PZ0.05 between the indicated samples (designated by lower case letters). (d and e) Percent
surviving Bak
 /  (d) and Bax
 /  (e) cells by PI exclusion after 3 days in culture in IL-7. Bars are the meanþS.D. of triplicate wells. Data are representative of three
independent experiments. *Po0.05 versus EtOH control for each genotype. (f) Survival ratios of Bak
 /  and Bax
 /  cells upon 3-day culture in IL-7. Bars are the
meanþS.E.M. of three experiments. Statistical signiﬁcance is depicted as in c.( g) Time course of survival of control and Bak
 / , Mcl-1
f/f, and Mcl-1
f/fERCre T cells in IL-7.
The mean 4OHT/EtOH survival ratios from two experiments are plotted versus time
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Cell Death and DiseaseCD44
hi cells, particularly CD4
þCD44
hi cells, was lower than
CD44
lo-cell survival. Upon Mcl-1 deletion, T-cell survival in
IL-4 was signiﬁcantly diminished (Figures 5a and b).
IL-15 promoted survival in CD44
hi cells (Figure 5b), and
CD44
hi cells in IL-15 exhibited reduced survival upon Mcl-1
deletion (Figure 5b). IL-15 at 10ng/ml also promoted the
survival of CD44
loCD8
þ T cells to a similar extent as IL-7
(Figure 5a). CD44
loCD4
þ T cells were not responsive to
IL-15: the percent survival with 1ng/ml IL-15 was similar to
that in RPMI (slightly higher with 10ng/ml, Figure 5a). These
results are consistent with a well-documented difference in
responsiveness to IL-15 between subsets, and could be due
to receptor expression levels.
32–34
The diminished survival upon Mcl-1 deletion (measured by
the4OHT/EtOH survivalratio) was more severein IL-4 than in
IL-7, indicating that cells cultured in IL-4 were more sensitive
to Mcl-1 deletion (Figure 5c). The survival ratio in IL-4 was not
signiﬁcantly different from that in RPMI alone. With IL-15,
sensitivity to Mcl-1 deletion correlated to the overall response
to IL-15: non-responsive CD44
loCD4
þ cells were more
sensitive than IL-15-responsive CD44
loCD8
þ and CD44
hi
cells (Figure 5c and data not shown).
Bak deﬁciency completely rescued IL-15-mediated survival
in Mcl-1-deleted responsive cells but not in non-responsive
(CD44
loCD4
þ) cells (Figure 5d). In contrast, Bak deﬁciency
did not completely rescue survival in CD4
þ or CD8
þ T cells
in IL-4 (Figure 5d). This is consistent with the fact that T cells
in IL-4 were similar to cells cultured in RPMI in Mcl-1
dependence, and the Bak
 /  background did not rescue
survival in RPMI.
Figure 3 Overexpression of Bcl-2 rescues cells from cytokine dependence but not dependence on Mcl-1. (a) Percent survival by PI exclusion of wild type (WT), Bak
 / ,
Bax
 / , Bcl-2
tg,andBim
 / TcellsincultureoftotalsplenocyteswithorwithoutIL-7for3days.*Po0.05,**Po0.01,***Po0.001versusWT control.Itemsnotmarkedwith
an asterisk are not signiﬁcant (PZ0.05). (b and c) Percent surviving cells by PI exclusion after 3-day culture of total splenocytes without (b) and with (c) IL-7. Cells
overexpressingBcl-2(Bcl-2
tg)andcellsexpressingonlyendogenousBcl-2(wtBcl-2)areshown.They-axisscaleisthesameforthewtBcl-2andadjacentBcl-2
tggraphs.Bars
are meanþS.D. of triplicate wells from a single experiment. Data are representative of four independent experiments. *Po0.05 versus EtOH control within each genotype.
(d and e) Survival ratios of wt Bcl-2 and Bcl-2
tg cells upon 3-day culture in medium alone (d) or in IL-7 (e). Bars are the meanþS.E.M. of 4–6 independent experiments.
*Po0.05 between the ERCre
þ samples.
wPo0.05 between ERCre
þ and ERCre
neg samples within the Bcl-2
tg genotype. Here, ns indicates that PZ0.05 between the
indicatedsamples (designated by lower-case letters). (f and g) Time course of survival of wt Bcl-2 and Bcl-2
tg, Mcl-1
f/f, and Mcl-1
f/fERCre T cells in RPMI alone (f) or with IL-7
(g). The mean of the 4OHT/EtOH survival ratios from 1–3 experiments is plotted versus time
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Cell Death and DiseaseWe also compared the enhancement of survival (over that
of Mcl-1
f/fERCre cells) between Bax
 /  and Bcl-2
tg genotypes
inIL-4orIL-15.Avalueof1indicatesthattheBax
 / orBcl-2
tg
background did not enhance survival. Neither Bax deﬁciency
nor Bcl-2 overexpression affected baseline survival in
IL-4 (Figure 5e). Upon Mcl-1 deletion, Bcl-2
tg but not Bax
 / 
cells had enhanced survival, indicating that, unlike in IL-7,
Bcl-2 and Mcl-1 share a role in promoting cell survival in IL-4
(Figure 5e). Neither the Bcl-2
tg nor the Bax
 /  background
greatly enhanced CD8
þ cell survival in IL-15, but Bcl-2
overexpression rescued both Mcl-1-sufﬁcient and Mcl-1-
deﬁcient CD4
þCD44
lo cells in IL-15 (Figure 5e).
As cells in vivo likely encounter multiple cytokines simulta-
neously,weassessedtheeffectofmultiplecytokinesonMcl-1
dependence.TcellsculturedwithamixofIL-4,IL-7,andIL-15
had a survival rate equal to that in any of the cytokines alone
(Figures5aandb).Strikingly,cellsculturedinthecytokinemix
were more dependent on Mcl-1 than cells in IL-7 or IL-15
(CD8
þ cells), and the 4OHT/EtOH survival ratio matched that
of IL-4 (Figure 5c). Like Mcl-1-deﬁcient cells in IL-4 alone, the
survival of Mcl-1-deﬁcient cells in the cytokine mix was
enhanced by Bcl-2 overexpression, indicating that the effect
of IL-4 on the role of Mcl-1 (favoring the shared versus
unshared role with Bcl-2) is dominant over the effect of IL-7.
Modulation of Bcl-2 family proteins by cc cytokines. To
determine why T cells cultured in IL-4, IL-7, and IL-15 had
differing levels of dependence on Mcl-1, we examined
protein expression for selected Bcl-2 family members upon
culture with different gc cytokines. IL-4, IL-7, and IL-15
induced higher expression of Mcl-1 and Bcl-2 than IL-2
or RPMI on day 3 (Figures 6a and b). Surprisingly, Bim
was upregulated in the pro-survival cytokines, and this
upregulation was most pronounced in IL-4 (Figures 6a
and b). The upregulation of Bim by IL-4 was also observed
on day 1 by intracellular staining (data not shown) and to a
Figure 4 Bim
 /  partially rescues survival of Mcl-1-deﬁcient cells in cytokine withdrawal. (a and b) Percent surviving cells (a), and ratio of survival in 4OHT/EtOH (b)o f
controlandBim
 / Mcl-1
f/fandMcl-1
f/fERCrecellsculturedinmediumalone.(candd)Percentsurvivingcells(c)andratioofsurvivalin4OHT/EtOH(d)ofcontrolandBim
 / 
Mcl-1
f/f and Mcl-1
f/fERCre cells cultured in IL-7. Data in a and c are the meanþS.D. of triplicate wells from a single experiment and are representative of two independent
experiments. *Po0.05 versus EtOH control within each genotype. The y-axis scale is the same for the wt Bim and adjacent Bim
 /  graphs. Data in b and d are the
meanþS.D.ratio of the ratios from one representative of two experiments. *Po0.05 between the ERCre
þ samples. *
athe Bim
 /  survival is signiﬁcantly lower.
wPo0.05
between ERCre
þ and ERCre
neg samples within the Bim
 /  genotype. Here, ns indicates that PZ0.05 between the indicated samples (designated by lower-case letters)
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Cell Death and Diseasemodest extent (increase of B20%) by western blotting
(Figure 6c). We examined the expression of Bak and Bax
by western blotting (day 1 was selected because of the low
cell survival by day 3 in some conditions). Bak levels were
slightly higher in pro-survival cytokines but were equivalent
between cytokines. Bax expression was highest in IL-4,
indicating another mechanism that could explain the
increased sensitivity of cells in IL-4 to Mcl-1 deletion.
However, because ofthe surprising induction of Bim bypro-
survival cytokines, the relative induction of Bim (normalized to
RPMI)was measured by ﬂowcytometry inCD44
lo and CD44
hi
cells. In all T-cell subsets, IL-4, IL-7, and IL-15 induced
Bim, but IL-4 resulted in the highest level of induction
(Figure 6d). The induction of Bim was greater in CD44
hi cells
than in CD44
lo cells. The induction of Bcl-2 in CD4
þ cells
illustrates the difference in responsiveness to IL-15 between
CD4
þCD44
lo and CD4
þCD44
hi cells (Figure 6d, bottom
right). Interestingly, IL-4 induced Bcl-2 to equal levels in
CD44
hiCD4
þ and CD44
loCD4
þ cells (2.8-fold and 2.7-fold,
respectively), but CD44
hi cells induced higher levels of Bim
than CD44
lo cells (4.2-fold versus 2.8-fold). The increased
Bim/Bcl-2 induction ratio could be the reason why
Figure5 IL-4,IL-7,andIL-15differentiallymodulatetheT-cellrequirementforMcl-1.(aandb)Percentsurvivingcellsafter3-daycultureofCD44
lo(a)andCD44
hi(b)cells
inIL-4 (1 and 10ng/ml), IL-7 (1ng/ml), IL-15 (1and 10ng/ml), ora mix ofall three cytokines (1ng/ml each). Data are the meanþS.D. oftriplicate wells froma singleexperiment
andarerepresentativeoftwoindependentexperimentsinwhichallconditionsweretestedsimultaneously.(c)4OHT/EtOHsurvivalratiosofCD44
loMcl-1
f/fERCrecellsafter3-
daycultureinthepresenceofdifferentcytokines.DataaremeanratiosþS.E.M.of2–5experiments.*Po0.05versusratioinRPMI.
wPo0.05versusratioinIL-7.(d)Survival
ofsortedCD44
loandCD44
hiBak
 / Mcl-1
f/fERCrecellsafter3-daycultureindifferentcytokines.BarsarethemeanþS.D.oftriplicatewells. (eandf)Theextenttowhichthe
Bax
 /  (e) and Bcl-2
tg (e and f) backgrounds enhance the survival of Mcl-1
f/fERCre CD44
lo and CD44
hi cells in IL-4 or IL-15 (10ng/ml; e) or in a mix of IL-4, IL-7, and IL-15
(1ng/mleach;f)isshown.Thebarsindicatetheratioofthesurvival(plustheS.D.ratio)ofMcl-1
f/fERCrecellsontheBax
 / orBcl-2
tgbackgroundoverthatoftheMcl-1
f/fERCre
cells for a single experiment. A ratio of 1 (no enhancement) is indicated by a dotted line. The Bcl-2
tg data are representative of two independent experiments
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Cell Death and DiseaseCD4
þCD44
hi cells had a more limited survival response to
IL-4 than CD4
þCD44
lo cells (Figure 5).
Discussion
Our data indicate that Mcl-1 has roles in multiple pathways:
cytokine-dependent and cytokine-independent. A model for
Mcl-1 activity in peripheral T cells is presented in Supplemen-
tary Figure S3. IL-4, IL-7, and IL-15 promote survival by
upregulating Mcl-1 and Bcl-2 (indicated by arrows). With
IL-7/IL-15 and sufﬁcient Bcl-2, the critical role for Mcl-1 is to
inhibit Bak (solid line), a biochemical function of Mcl-1 but not
Bcl-2.
35 This is consistent with our previous observations in
the thymus,
19 a cytokine-rich environment. Inhibiting Bim is
not a critical function of Mcl-1 in the presence of IL-7 or IL-15
(in responding cells), likely due to the induction of sufﬁcient
Bcl-2toneutralizeBim.Baxinhibitionisnotamajorfunctionof
Mcl-1 in the presence of cytokines, but it is not clear whether
Figure 6 Regulation of Bcl-2-family protein expression by gc cytokines. (a) Histograms of intracellular staining for Bcl-2, Mcl-1, and Bim on day 3. Cell populations were
ﬁrst gated on live cells by FSC and SSC, then on the CD44
low population within the CD4
þ and CD8
þ T-cell gates. The shaded histogram is the isotype control. Data are
representative of 1–2 experiments. (b) Mean ﬂuorescence intensity (MFI) of Mcl-1, Bcl-2, and Bim staining. The mean of duplicate wells in each condition from a single
experimentisshown,andtheisotypecontrolMFIwasaveragedfromalloftheconditions.(c)WesternblotofBak,Bax,andBimexpressioninTcellsculturedwithcytokinesfor
22h. The corresponding loading control (b-tubulin) for each blot is shown. The estimated relative intensities of Bak, Bax, and Bim, normalized to loading controls, were
calculated as described in Materials and methods, and are shown underneath each blot. Lane 1 (‘Fresh’ T cells) was arbitrarily deﬁned as 1, and the number indicates the
intensityrelativetoLane1.ForBim,thecombinedintensityfortheBimELandBimLisoformswasused.(d)TheinductionofBim(left)andBcl-2(right)iscomparedbetweenthe
differentconditionsindifferentT-cellsubsets.ThebarsindicatethemeanoftwoexperimentsinwhichtheMFIsofduplicatewellswereaveragedanddividedbytheMFIofone
isotypecontrolwell before normalizingto thevalue for RPMI.For Bcl-2,only CD4
þ cellsare shownto demonstratethedifferencein responsivenessto IL-15 betweenCD44
lo
and CD44
hi cells
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Cell Death and DiseaseBax is kept inactive by direct inhibition by Bcl-2 or by a lack of
activating factors, leading to the retention of Bax in an inactive
conformation or location.
Although IL-4 upregulated anti-apoptotic proteins to a
similar level as IL-7 and IL-15, IL-4 induced higher levels of
Bax and Bim. Bim induction by IL-4 shifts the dominant role of
Mcl-1 toward its shared role with Bcl-2. T cells in IL-4 were
more sensitive to Mcl-1 deletion, and did not exhibit the same
pattern of rescue by the different genotypes as cells in IL-7/
IL-15.TheenhancedupregulationofBimis,toourknowledge,
a novel function of IL-4 for which the biological reason and
mechanism are unknown. STAT6, a molecule downstream
ofIL-4, butnot IL-7or IL-15,isdispensable forthepro-survival
effect of IL-4, but remains a candidate mechanism for the
enhanced upregulation of Bim.
2,31
Mcl-1 and Bcl-2 share a role in protecting cells under
conditions in which cytokines are scarce or absent, as
evidenced by the partial rescue of Mcl-1-deﬁcient cells by
Bcl-2 overexpression. Deﬁciency in Bim and, to a lesser
extent, Bax partially rescued Mcl-1-deﬁcient cell survival in
RPMI. Therefore, Bim is a central mediator of the Mcl-1/Bcl-2
shared pathway during cytokine withdrawal (Supplementary
Figure S3), and the cytokine withdrawal-induced apoptotic
pathway occurs preferentially but not exclusively through
Bax. As the rescue of cytokine-starved cell survival by Bim
deﬁciency did not equal that of Bcl-2 overexpression, other
BH3-only proteins may promote apoptosis during cytokine
withdrawal. Additionally, Bcl-2 overexpression did not fully
rescue the survival of Mcl-1-deﬁcient cells under cytokine
withdrawal, implying that Mcl-1 also has a separate, speciﬁc
role. Although Bak deﬁciency did not rescue under these
conditions,Mcl-1 could still inhibit Bak (indicated by the dotted
lineinSupplementaryFigureS3).TheactivationofBim,which
induces apoptosis through Bax, could mask the effect of Bak
deﬁciency. To address this possibility, Bak and Bim must be
simultaneouslyneutralized,perhapsincombinationwithother
BH3-only proteins.
Our data indicate that IL-7, IL-15, and IL-4 all promote
T-cell survival but differentially regulate Bcl-2-family protein
expression and the role of Mcl-1. By examining the effects of
differentcytokinesindividuallyandtogether,wedemonstrated
howsubtledifferencesinthe cellularresponse tothesesimilar
cytokines affect T-cell survival by shifting the balance
between the different roles of Mcl-1, speciﬁcally its role in
antagonizing Bak and its shared role with Bcl-2 antagonizing
Bim/Bax. Because of the increased upregulation of Bim by
IL-4, T cells cultured with a mix of IL-4, IL-7, and IL-15 relied
more heavily on the Mcl-1/Bcl-2 shared pathway of survival
than Tcells inIL-7 orIL-15 alone, whichrelied onthe inhibition
of Bak.
Consistentwithourresults,arecentstudynotedexpression
of Bim in vivo in response to IL-7 and IL-15 (IL-4 not tested).
36
This group demonstrated that expression of sufﬁcient Bcl-2 to
neutralize the Bim is critical in effector/memory T-cell
survival.
36 As Mcl-1 is also expressed in effector and memory
T cells,
18 the speciﬁc activity of Mcl-1 likely inﬂuences the
effective balance of Bcl-2 and Bim in these cells. The balance
between the speciﬁc and shared functions of Mcl-1/Bcl-2 may
be critically important for regulating memory. Depending on
the identity and concentration of cytokines present, Mcl-1 will
be more or less necessary to enhance Bcl-2 activity. As IL-4,
which is produced during a Th2-polarized immune response,
skews the primary role of Mcl-1 toward inhibiting the Bim/Bax
pathway, the susceptibility of T-cell subsets to apoptosis in
Th1 versus Th2 conditions should be closely examined. As
methods of detection continue to improve, it will be important
to determine the precise local concentrations of cytokines in
different niches, such as in circulation, or within lymphoid
organs. Combined with our data, this will allow a better
understanding of the processes that regulate cell survival
in vivo.
In addition to the implications of our data on normal T-cell
biology, the role of Mcl-1 and the skewing of the apoptotic
pathway by different cytokines could potentially be important
in tumor biology. The Bcl-2-family proteins are frequently dis-
regulated during oncogenesis, including that of the lymphoid
system. The drug ABT-737, a synthetic inhibitor of Bcl-2,
Bcl-xL, and Bcl-w, is a potent antitumor agent.
37 As ABT-737
does not inhibit Mcl-1, tumor cell resistance to ABT-737
correlates with Mcl-1 levels.
38,39 Intriguingly, factors such as
cytokines may inﬂuence the extent to which tumor cells
depend on the Mcl-1/Bcl-2 shared versus unique pathway of
survival. Although tumor immunity is typically associated with
cytotoxic T-cell responses, the skewing of the apoptotic
pathway toward the shared Bim/Bax pathway by IL-4 has
interesting implications on how a Th2 response or IL-4 alone
might indirectly promote tumor cell death. It is possible
that this pathway could be manipulated therapeutically to
enhance the efﬁcacy of apoptotic drugs, such as ABT-737,
that preferentially trigger the Bak or the Bim/Bax apoptotic
pathway.
Materials and Methods
Mice. Mcl-1
f/f mice were generated as described previously and were
backcrossed at least seven generations onto the C56BL/6 strain background.
40
The in vitro deletion of Mcl-1 was achieved using the inducible knockout system
in which ERCre is expressed from the Rosa26 gene locus.
23 Bak
 / , Bax
 / , and
Bim
 /  mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA).
Bcl-2
tg mice
27 were provided previously by Dr. Motonari Kondo. Mice were
maintained in speciﬁc pathogen-free conditions, and were utilized under protocols
approved by the Duke University Institutional Animal Care and Use Committee.
Antibodies, cytokines, and other reagents. The antibodies used for
sorting and surface staining for ﬂow cytometry (against CD4, CD8, CD44, and
TCRb)wereobtainedfromBiolegend(SanDiego,CA,USA).Rabbitanti-Bak,-Bax,
-Bim, and -b-tubulin, as well as the horseradish peroxidase (HRP)-conjugated
anti-rabbit antibody were from Cell Signaling Technology (Danvers, MA, USA).
Rabbit anti-Mcl-1 was from Rockland Immunochemicals (Gilbertsville, PA, USA).
The whole rabbit IgG isotype control and phycoerythrin (PE)-anti-rabbit IgG were
from Jackson Immunoresearch (West Grove, PA, USA). The PE-conjugated Bcl-2
staining kit was obtained from BD Biosciences (San Jose, CA, USA). Murine IL-7,
IL-4, and IL-15 were purchased from Peprotech (Rocky Hill, NJ, USA), and were
dissolved according to the manufacturer’s instructions. Cytokines were then diluted
to 1000  stocks in medium (RPMI) and stored at  801C until use. Recombinant
hIL-2 was obtained from the Duke University Pharmacy (Durham, NC, USA) and
wasdilutedtoastockconcentrationof10
5units(U)/mlinmediumandstoredat41C.
4OHT was obtained from Sigma (St. Louis, MO, USA), and was dissolved in 100%
EtOH to a stock concentration of 500mM. Propidium iodide (PI) was obtained from
Sigma and was dissolved in phosphate-buffered saline (PBS) to a 500  stock
concentration of 1mg/ml. All the media and its related solutions were from
Invitrogen (Carlsbad, CA, USA).
Total splenocyte cultures and deletion of Mcl-1. Spleens were
smashed and ﬁltered through a nylon mesh to make a single-cell suspension in
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temperature, and the remaining cells were washed, counted, and resuspended
in complete RPMI (þ10% fetal bovine serum (FBS) and 1  non-essential
amino acids, L-glutamine, and penicillin/streptomycin) to a concentration of
2–4 10
6cells/ml. Although the cell concentrations used varied slightly between
different experiments, the cell concentrations of the different samples were kept
constant within each experiment. A total of 100 ml of cells was plated in triplicate
onto 96-well Corning Costar plates with an equal volume of complete RPMI
containing4OHTor EtOHandcytokinesas appropriate(ﬁnal cell concentration was
1–2 10
6cells/ml). 4OHT was used at a ﬁnal concentration of 100nM, and the
EtOH vehicle control was prepared by adding an equivalent volume of 100% EtOH
tothecontrolmedium.TheﬁnalconcentrationofIL-7was1ng/ml,theconcentration
of hIL-2 was 100U/ml,and the concentrations of IL-15 andIL-4 were both 10ng/ml,
unless otherwise indicated in the ﬁgure. Cells were cultured in a 5% CO2,3 7 1C
humidiﬁed atmosphere for 1, 3, or 5 days before analysis. Unless otherwise
indicated, the data shown are from a 3-day culture of the cells.
Sorting of CD44
hi and CD44
lo cells. For experiments using sorted T cells,
splenocytes as well as mesenteric and inguinal lymph nodes were collected,
and RBCs were lysed as described above. Cells were resuspended in 2% FBS in
PBS for T-cell enrichment before sorting. T cells were enriched using the EasySep
T-Cell Enrichment Kit (Stem Cell Technologies, Vancouver, BC, Canada), following
the manufacturer’s instructions. Cells were surface stained and sorted into CD44-
high(CD44
hi)andCD44-low(CD44
lo)populationsonaFACSDiva(BDBiosciences)
or MoFlo (Beckman Coulter, Miami, FL, USA) cell sorter. To increase the plating
density of sorted cells, CD4
þ and CD8
þ cells were cultured together within the
CD44
hi and CD44
lo populations. Cells were cultured as described above, except
with cell concentrations of 0.1–1 10
6cells/ml.
Flow cytometry and measurement of cell survival. Cells were
transferred into a U-bottom 96-well plate, centrifuged, and resuspended in 25%
24G2 hybridomasupernatant(Fcblock)in2%FBS.Aftera10–15min blockingstep,
cells were stained with antibodies to surface molecules for 15–30min. Cells were
washed with 2% FBS, and were resuspended in 2% FBS containing PI at 2mg/ml.
Cells were kept on ice throughout the staining, and until analysis on a FACSCanto
cytometer (BD Biosciences). Flow cytometry data were analyzed using FlowJo
software (Tree Star Inc., Ashland, OR, USA). Events were initially gated on live
and dead cells (and ‘debris’ was removed) based on forward and side scatter
(FSC and SSC). Then CD4
þTCRb
þ and CD8
þTCRb
þ populations were gated
(in some cases with the addition of the marker CD44), and the percentage of cells
in each population that was negative for PI staining was determined.
Intracellular staining for Mcl-1, Bcl-2, and Bim. T cells were enriched
as described above using the EasySep T Cell Enrichment Kit (Stem Cell
Technologies), following the manufacturer’s instructions. Cells were plated in a
96-well plate at a density of 1–2 10
6cells/ml in the presence of IL-2 (100U/ml),
IL-4 (10ng/ml), IL-7 (1ng/ml), or IL-15 (10ng/ml) or without cytokine. After 3 days
in culture, cells were surface-stained as described above, ﬁxed in 1%
paraformaldehyde on ice for 20min, and stored at 41C overnight. Cells were
permeabilized with 0.1% saponin in 2% FBS. For the Mcl-1 and Bim stains, the
permeabilization buffer contained 5% donkey serum and 10% 24G2 supernatant.
Afterpermeabilization, cells werecentrifuged andresuspendedin 90ml of thesame
buffer. PE-anti-Bcl-2 and the corresponding isotype control were added at
10ml/stainasperthemanufacturer’srecommendation.Stocksolutionsofanti-Mcl-1
(0.1mg/mlin50%glycerolinPBS)andanti-Bim(0.234mg/mlin50%glycerol)were
diluted so as to add 10ml of the diluted antibody solution to yield a ﬁnal dilution of
1:100(Mcl-1)or1:200(Bim).Fortheisotypecontrols,stocksolutionsofrabbitIgG
were prepared to equivalent concentrations in 50% glycerol in PBS, and were
diluted and addedto the appropriate wells accordingly. For each condition, one well
was stained with each isotype control and duplicate wells were used for each of the
speciﬁc antibody stains. After primary antibody staining, cells were washed in 0.1%
saponin two times, and cells for the Mcl-1 and Bim stains, as well as the isotype
controls, were incubated in PE-anti-rabbit IgG (1ml/well) in 0.1% saponin. Cells
were washed two times and were analyzed immediately using a FACSCanto
cytometer (BD Biosciences). For the subsequent analysis, only those cells in the
‘live’ gate by forward and side scatter were used.
To assess Mcl-1 deletion in the different genotypes by measuring Mcl-1 protein
levels, splenocytes were cultured under the same conditions used to assess
survival. The Mcl-1 staining was performed as described above. The cell-survival
data for each experiment in which Mcl-1 staining was performed were conﬁrmed to
represent a typical experiment for that genotype. To determine whether the double-
knockoutcellsrescuedthesurvivalofMcl-1-deﬁcientcellsbyselectingforundeleted
cells, the Mcl-1 protein levels were compared between knockout and wild-type cells
for Bak, Bim, and Bak with and without the deletion of Mcl-1. To do this, the mean
ﬂuorescence intensities (MFIs) of duplicate Mcl-1-stained wells were averaged,
and divided by the MFI of the isotype control well for each condition and cell type to
obtain a value for Mcl-1 expression. Then, the ratio of the Mcl-1 expression level in
knockout (Bak, Bim, or Bax) cells to that in wild-type cells was calculated
to determine if any increase in expression over wild-type could be observed in the
knockout.
Western blotting. Enriched T cells were prepared as described and were
plated onto six-well plates at a density of 2 10
6cells/ml (6ml, 12 10
6cells/well)
in the presence or absence of cytokines. After 1 day (24h), the cells were collected
into 15-ml conical tubes, washed with PBS, and resuspended in 150ml of SDS
sample buffer (50mM Tris HCl, pH 6.8 and 2% SDS) containing 20mM
freshly added dithiothreitol (DTT). Cells were lysed on ice for 30min, then 30mlo f
6  sample buffer containing bromophenol blue and glycerol (at ﬁnal
concentrations of 0.1% and 10%, respectively) was added, and samples were
boiled for 5min. Protein lysate aliquots were stored at  801C until use. For ‘fresh’
T cells, an equal number of cells were lysed immediately after T-cell enrichment,
and the sample was prepared and stored as described. Protein samples were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and were transferred to a polyvinylidene ﬂuoride (PVDF) membrane
(ImmobilonP; Millipore, Billerica, MA, USA). To allow simultaneous staining of Bak,
Bax, or Bim and the loading control (b-tubulin), the membranes were cut at the 37-
kDa marker, and thetop half was used for b-tubulin, whilethebottom half was used
for the Bcl-2 family protein. The membranes were blocked with 5% milk in PBS-T
(PBS containing 0.2% Tween-20) at room temperature with gentle shaking for
45min, followed by incubation in primary antibodies (all used at 1:1000 in 3%
bovine serum albumin (BSA) in PBS-T) for 1–1.5h also at room temperature
with gentle shaking. After washing in PBS-T (3 10min), the HRP-conjugated
anti-rabbit secondary antibody was added (1:5000 in 3% BSA in PBS-T), and the
membranes were gently shaken at room temperature for 1h. The membraneswere
washed (3 10min in PBS-T) and incubated in the SuperSignal West Pico
Substrate (Pierce/Thermo Scientiﬁc, Rockford, IL, USA) for 5min before the signal
was detected by exposure to ﬁlm.
Image analysis for western blotting. To estimate the relative intensities
of the Bak, Bax, and Bim bands, corrected by the b-tubulin loading control bands,
the gel analysis tools of the ImageJ software (http://rsbweb.nih.gov/ij/) were used.
For each blot, a histogram was plotted for the signal in each lane, and the peak
corresponding to the band was deﬁned by drawing a line across the bottom of the
peak based on the signal in the background region. The area under the peak was
calculated relative to Lane 1 (fresh T cells, arbitrarily set to 1). To correct for slight
differences in protein loading, the relative intensity of Bak, Bax, or Bim was divided
by the relative intensity of the corresponding b-tubulin band to yield a loading-
corrected estimated intensity of Bak, Bax, or Bim relative to Lane 1.
Statistical analyses. Additional data analysis and the graphing of data were
performed using Prism (GraphPad Software, Inc., La Jolla, CA, USA). The mean
percent survival of triplicate wells in each condition was determined for each
experiment.Theﬁguresfromrepresentativeindividualexperiments depictthemean
percent survival plus the standard deviation (S.D.) of triplicate wells. To determine
the Mcl-1-dependent survival ratio, the mean survival of the wells cultured in
4OHT was divided by the mean survival of the corresponding wells in EtOH
control medium (labeled EtOH in ﬁgures). The S.D. of the 4OHT/EtOH ratio for
individual experiments with triplicate wells was calculated using the equation
S.D.ratio¼O([S.D.EtOH]
2þ[S.D.4OHT]
2). To compare survival between genotypes
(as in Figure 5e) the ratio of the survival of Bcl-2
tg or Bax
 /  cells to that of Bcl-2/
Baxwild-typecells fromthe sameexperiment (allon theMcl-1
f/fERCre background)
was calculated for each condition, and the S.D.ratio was used. To combine multiple
experiments, the 4OHT/EtOH survival ratios of the individual experiments were
averaged, and the mean plus standard error of the mean (S.E.M.) are depicted in
theﬁgures.Toassessstatisticalsigniﬁcance,anunpairedStudent’sttestwasused,
and P-values less than 0.05 were considered to be signiﬁcant. For some ﬁgures
(as indicated in the legends), a ‘graded’ indication of signiﬁcance is depicted using
the following symbols: *Po0.05; **Po0.01; and ***Po0.001.
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